Abstract:Background aims: Adoptive cellular therapy with immune effector cells (IECs) has shown promising efficacy against some neoplastic diseases as well as potential in immune regulation. Both inherent variability in starting material and variations in cell composition produced by the manufacturing process must be thoroughly evaluated with a validated method established to quantify viable lymphocyte subtypes. Currently, commercialized immunophenotyping methods determine cell viability with significant errors in thawed products since they do not include any viability staining. We hereby report on the validation of a flow cytometry-based method for quantifying viable lymphocyte immunophenotypes in fresh and cryopreserved hematopoietic cellular products. Methods: Using fresh or frozen cellular products and stabilized blood, we report on the validation parameters accuracy, uncertainty, precision, sensitivity, robustness and contamination between samples for quantification of viable CD3+, CD4+ T cells, CD8+ T cells, CD3-CD56+CD16+/- NK cells, CD19+ B cells and CD14+ monocytes of relevance to fresh and cryopreserved hematopoietic cellular products using the Cytomics FC500 cytometer (Beckman Coulter). Results: The acceptance criteria set in the validation plan were all met. The method is able to accommodate the variability in absolute numbers of cells in starting materials collected or cryopreserved from patients or healthy donors (uncertainty of ≤20% at three different concentrations), stability over time (compliance over 3 years during regular inter-laboratory comparisons) and confidence in meaningful changes during cell processing and manufacturing (intra-assay and intermediate precision of 10% coefficient of variation). Furthermore, the method can accurately report on the efficacy of cell depletion since the lower limit of quantification was established (CD3+, CD4+ and CD8+ cells at 9, 8 and 8 cells/µL, respectively). The method complies with Foundation for the Accreditation of Cellular Therapy (FACT) standards for IEC, FACT-Joint Accreditation Committee of ISCT-EBMT (JACIE) hematopoietic cell therapy standards, International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Q2(R1) and International Organization for Standardization 15189 standards. Furthermore, it complies with Ligand Binding Assay Bioanalytical Focus Group/American Association of Pharmaceutical Scientists, International Council for Standardization of Hematology/International Clinical Cytometry Society and European Bioanalysis Forum recommendations for validating such methods. Conclusions: The implications of this effort include standardization of viable cell immunophenotyping of starting material for cell manufacturing, cell selection and in-process quality controls or dosing of IECs. This method also complies with all relevant standards, particularly FACT-JACIE standards, in terms of enumerating and reporting on the viability of the "clinically relevant cell populations."

[Evaluation of Two Methods for Counting Residual White Blood Cells in Thrombocytaphoresis Concentrates].

Comparative Study for Measurement of Residual Leucocytes in Leucodepleted Red Blood Cells by Two Different Methods

Assessment of a Five-Color Flow Cytometric Assay for Verifying Automated White Blood Cell Differentials.

Compare the accuracy and precision of Coulter LH780, Mindray BC-6000 Plus, and Sysmex XN-9000 with the international reference flow cytometric method in platelet counting

Can Immature Granulocyte Counting be Utilized in the Selection of Samples for Flow Cytometric Enumeration of Stem Cells?

True volumetric counting of CD34+ cells using flow cytometry

Accuracy evaluation of PLT-F method on low concentration of platelet counting

Counting of leukocytes in samples from G-CSF mobilized donors, leukapheresis products, and cord blood: the performances of an analyzer with dedicated profiles

Research on absolute enumeration of CD34~+ cells detected by CyFlow Space flow cytometry

Performance evaluation of WBC and RBC counting with the Beckman-Coulter Z2 cell counter

Validation of a flow cytometry-based method to quantify viable lymphocyte subtypes in fresh and cryopreserved hematopoietic cellular products

Comparison of Volumetric and Bead‐Based Counting of CD34 Cells by Single‐Platform Flow Cytometry

Evaluation of total leukocytes count by flow cytometry with Beckman Coulter® DXH900 in the presence of platelet aggregates

A Novel Method for Enumeration of Basophiles in Peripheral Blood by Flow Cytometry

Optical Platelet Counts can be Used as a Recheck Method in Low Platelet Samples in Complete Blood Count

Establishment and evaluation on the microscopy rule for nucleated red blood cell by SYSMEX XN-9000 automatic hematology analyzer

[Standardization and Quality Control in Flow Cytometric Enumeration of CD34(+) Cells]

Establishment of Method and Verification for Leukocyte Differential Count of Sysmex Hematology Analyzer

Evaluation of a routine hematology analyzer for quality control of leukoreduced plasma

Single-step Preparation and Image-Based Counting of Minute Volumes of Human Blood

Validation of the Sysmex XN analyser and Blood Bank mode for the quality and safety of donor blood and transfusion products